Pricing Log in Create free account

Sagimet Biosciences Inc. (SGMT) vs Zevra Therapeutics, Inc. (ZVRA)

Sagimet Biosciences Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Sagimet Biosciences Inc. and Zevra Therapeutics, Inc. are of similar size ($641.5M and $626.6M). Sagimet Biosciences Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 9.0×. Zevra Therapeutics, Inc. has the higher net margin (50.7% vs 0.00%) and the higher return on invested capital (129.5% vs −205.2%). Across the 13 metrics below, Zevra Therapeutics, Inc. leads on 10 and Sagimet Biosciences Inc. on 3.

Valuation

Metric SGMT ZVRA Biotechnology median
P/E n/m 9.00 10.60
P/S n/m 4.64 9.40
P/B 2.04 2.87 2.13
Price to free cash flow n/m 7.88 25.18
EV/EBITDA n/m 6.61 0.66
EV/Sales n/m 3.99 9.02
Earnings yield (13.03%) 11.11% (32.88%)
Free cash flow yield (8.00%) 12.69% (23.13%)

Profitability

Metric SGMT ZVRA Biotechnology median
Gross margin 0.00% 95.44% 68.51%
Operating margin 0.00% 60.78% 0.00%
Net margin 0.00% 50.73% 0.00%
Free cash flow margin 0.00% 58.93% 0.00%
Return on equity (24.37%) 40.29% (51.96%)
Return on assets (23.49%) 25.69% (46.06%)
Return on invested capital (205.24%) 129.48% 0.00%

Growth

Metric SGMT ZVRA Biotechnology median
Revenue growth (TTM) — 75.10% 6.76%
EPS growth (last fiscal year) (8.97%) 159.21% 29.88%
Revenue growth, 5-year CAGR — 51.62% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SGMT ZVRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.02 5.46 4.97
Net debt to EBITDA 1.98 39.03 1.01

Dividend

Metric SGMT ZVRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SGMT ZVRA Biotechnology median
Market cap 641.51m 626.59m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack